Skip navigation
Speakers

Enhance Process and System Interopability to Optimize Data Quality, Improve Trial Efficiency and Ensure Protection of Human Subjects

November 13-14, 2019
  • Philadelphia, PA

Abby Abraham
Vice President of Data Analytics and Risk-Based Monitoring
OmniComm Systems, Inc.

Artem Andrianov, Ph.D.
CEO
Cyntegrity

Julie Solbjerg Appel
Clinical Data Surveillance Specialist
Novo Nordisk A/S

Michael Arlotto
President and Founder
Remarque Systems

Mary Arnould
Director/RBM Lead, Clinical Science Operations
Astellas

Lisa G. Berdan, PA, MHS
Director, Global MegaTrials
Duke Clinical Research Institute

Stephanie Clark
Director, Risk-Management Central Monitoring
Janssen R&D

John (Jay) Daly
Clinical Study Risk Manager, Clinical Data Operations, Technology, and Standards
UCB Biosciences, Inc.

Laureen Dorschel
Clinical Study Risk Manager, Clinical Data Operations, Technology and Standards,
UCB Biosciences, Inc.

Sean Graham
Manager, Risk Management, Central Monitoring
Janssen R&D

Lewis Hower, BSc
Director, Risk Management, Central Monitoring
Janssen R&D

Andy Lawton
Director
Risk-Based Approach Ltd

Esther M. Huffman O’Keefe
Associate Director, Monitoring, Global Clinical Operations
Regeneron

Zabir Macci
Associate Director, Process Design & Analytics
Centralized Monitoring
IQVIA

Amy Neubauer
Director, Data Quality Oversight
Alkermes, Inc.

Morten Thorup Pedersen
Risk-Based Monitoring Specialist
Novo Nordisk A/S

Erin Reynolds
Manager Clinical Analytics, Data and Statistical
Science Research & Development
AbbVie

Kristin Stallcup
Senior Director, Xcellerate Customer Success
Covance Inc

Phi Tat
Central Monitor (Sr. Associate)
Pfizer

Steve Young
Chief Operations Officer
CluePoints

Abby Abraham
Vice President of Data Analytics and Risk-Based Monitoring
OmniComm Systems, Inc.

Artem Andrianov, Ph.D.
CEO
Cyntegrity

Julie Solbjerg Appel
Clinical Data Surveillance Specialist
Novo Nordisk A/S

Michael Arlotto
President and Founder
Remarque Systems

Mary Arnould
Director/RBM Lead, Clinical Science Operations
Astellas

Lisa G. Berdan, PA, MHS
Director, Global MegaTrials
Duke Clinical Research Institute

Stephanie Clark
Director, Risk-Management Central Monitoring
Janssen R&D

John (Jay) Daly
Clinical Study Risk Manager, Clinical Data Operations, Technology, and Standards
UCB Biosciences, Inc.

Laureen Dorschel
Clinical Study Risk Manager, Clinical Data Operations, Technology and Standards,
UCB Biosciences, Inc.

Sean Graham
Manager, Risk Management, Central Monitoring
Janssen R&D

Lewis Hower, BSc
Director, Risk Management, Central Monitoring
Janssen R&D

Andy Lawton
Director
Risk-Based Approach Ltd

Esther M. Huffman O’Keefe
Associate Director, Monitoring, Global Clinical Operations
Regeneron

Zabir Macci
Associate Director, Process Design & Analytics
Centralized Monitoring
IQVIA

Amy Neubauer
Director, Data Quality Oversight
Alkermes, Inc.

Morten Thorup Pedersen
Risk-Based Monitoring Specialist
Novo Nordisk A/S

Erin Reynolds
Manager Clinical Analytics, Data and Statistical
Science Research & Development
AbbVie

Kristin Stallcup
Senior Director, Xcellerate Customer Success
Covance Inc

Phi Tat
Central Monitor (Sr. Associate)
Pfizer

Steve Young
Chief Operations Officer
CluePoints